Breakdown | ||||
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
186.27B | 172.99B | 173.86B | 112.98B | 68.68B | Gross Profit |
17.83B | 16.06B | 16.32B | 8.45B | 3.07B | EBIT |
13.29B | 13.73B | 14.40B | 4.84B | 4.31B | EBITDA |
14.71B | 17.10B | 10.56B | 9.01B | 8.01B | Net Income Common Stockholders |
8.25B | 6.07B | 5.11B | 2.33B | 1.86B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
39.00B | 36.88B | 31.44B | 24.38B | 23.37B | Total Assets |
172.97B | 165.02B | 137.45B | 122.44B | 116.86B | Total Debt |
50.86B | 48.35B | 46.86B | 45.03B | 43.98B | Net Debt |
20.15B | 15.70B | 22.54B | 28.09B | 28.34B | Total Liabilities |
101.01B | 102.98B | 89.19B | 75.11B | 67.37B | Stockholders Equity |
59.54B | 51.70B | 39.85B | 38.89B | 40.80B |
Cash Flow | Free Cash Flow | |||
2.62B | 4.94B | 1.91B | 870.66M | ― | Operating Cash Flow |
15.54B | 15.45B | 6.19B | 8.49B | 1.70B | Investing Cash Flow |
-10.66B | ― | ― | ― | ― | Financing Cash Flow |
-8.61B | ― | 7.89B | 422.30M | ― |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $155.92B | 7.90 | 22.95% | 2.61% | 12.14% | 53.33% | |
74 Outperform | $487.16B | 11.94 | 27.63% | 1.87% | 3.41% | 60.46% | |
72 Outperform | $1.16T | 23.00 | 23.91% | 0.88% | 33.89% | 45.52% | |
71 Outperform | $106.77B | 5.34 | 20.63% | 4.50% | 2.84% | ― | |
56 Neutral | HK$300.89M | 11.52 | 0.44% | ― | 23.25% | -22.03% | |
55 Neutral | €4.77B | ― | -14.04% | ― | -31.64% | -253.13% | |
49 Neutral | $1.95B | -1.37 | -21.20% | 3.73% | 0.84% | -29.84% |
China Molybdenum Co, operating under the name CMOC Group Limited, has announced a final cash dividend for the year ending December 31, 2024. The dividend is set at RMB 2.55 per 10 shares, with shareholder approval scheduled for May 30, 2025. The announcement includes updated information on the withholding tax rates applicable to different types of shareholders, with non-resident enterprises facing a 10% tax rate and resident individuals a 20% rate. The specifics of the dividend payment, including the default currency and payment date, are yet to be announced.
CMOC Group Limited announced the resignation of its non-executive director and chairman, Mr. Yuan Honglin, and executive director and vice chairman, Mr. Li Chaochun, due to personal reasons. Their departures will not affect the company’s operations or board functionality. The company has proposed the appointment of Mr. Que Chaoyang and Mr. Liu Jianfeng as new executive directors, subject to shareholder approval. These appointments bring extensive experience in mining, investment, and corporate governance, potentially strengthening CMOC’s strategic and operational capabilities.
China Molybdenum Co has announced the composition of its board of directors and the roles they will serve within the company’s committees. This update provides clarity on the leadership structure, which could impact the company’s strategic direction and governance, potentially affecting its market positioning and stakeholder interests.
CMOC Group Limited, a joint stock company incorporated in China, has announced its annual general meeting for 2024, scheduled to be held on May 30, 2025, in Luoyang City, Henan Province. The meeting will address several resolutions, including the approval of financial reports, profit distribution plans, and the appointment of external auditors for 2025. Additionally, the company will consider proposals for purchasing structured deposits and wealth management products, as well as authorizations for issuing debt financing instruments and additional shares. These resolutions are aimed at strengthening the company’s financial management and operational strategies.
China Molybdenum Co, a joint stock company incorporated in the People’s Republic of China, has announced a meeting for H Shareholders scheduled for May 30, 2025. The meeting aims to consider and approve special resolutions regarding the cancellation of repurchased shares and the reduction of registered capital, as well as changes to the registered capital and amendments to the company’s Articles of Association. This announcement indicates a strategic move to adjust the company’s capital structure, which could impact its financial positioning and shareholder value.
CMOC Group Limited has announced its unaudited financial results for the first quarter of 2025, reporting a slight decrease in operating revenue by 0.25% compared to the same period last year. However, the company saw a significant increase in net profit attributable to shareholders, which rose by 90.47%, indicating strong profitability despite a substantial drop in net cash flow from operating activities by 76.02%. The company’s total assets and net assets attributable to shareholders also increased, reflecting a stable financial position and potential positive outlook for stakeholders.
CMOC Group Limited has announced that a board meeting will be held on April 25, 2025, to consider and approve the publication of its quarterly results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
CMOC Group Limited announced a significant increase in the production of its main products, copper, cobalt, and niobium, during the first quarter of 2025, with respective year-on-year increases of 15.65%, 20.68%, and 4.39%. This growth, coupled with higher sales prices, resulted in better-than-expected operating indicators, positioning the company for strategic expansion and high-quality development throughout the year.
In its annual results announcement for 2024, CMOC Group Limited reported record-high operating indicators, with a 14.37% increase in revenue and a 64.03% rise in net profit. The company achieved historic production volumes across its key products, including copper and cobalt, and maintained a strong ESG performance, securing an AA rating in MSCI ESG and inclusion in FTSE Russell’s Socially Responsible Indexes. CMOC also advanced its production capabilities with successful project completions and expansions in the DRC, including a new hydropower station project, reinforcing its strategic growth and sustainability efforts.
CMOC Group Limited has announced a final cash dividend of RMB 2.55 per 10 shares for the financial year ending December 31, 2024. The announcement, made on March 21, 2025, indicates the company’s commitment to returning value to its shareholders. However, specific details such as the ex-dividend date, payment date, and withholding tax information are yet to be disclosed, leaving stakeholders awaiting further updates.
CMOC Group Limited has announced the proposed cancellation of 104,930,443 repurchased A shares under its A Share Repurchase Plan (Phase III) as the 36-month period for utilizing these shares is nearing expiration. This move, pending shareholder approval, will reduce the company’s total issued shares, reflecting a change in its registered capital. Additionally, the company plans to amend its Articles of Association to align with this capital change, subject to shareholder approval. These actions are part of the company’s strategic management of its share capital and compliance with regulatory requirements.
CMOC Group Limited has announced an online briefing session for its 2024 annual results, scheduled for March 25, 2025. The session will be conducted via the SSE Roadshow platform, allowing investors to interact with the company’s leadership and discuss its performance and operations. This initiative reflects CMOC’s commitment to transparency and engagement with stakeholders, potentially enhancing investor confidence and market positioning.
CMOC Group Limited has announced a forthcoming board meeting scheduled for March 21, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend, which could have implications for shareholders and reflect the company’s financial health and strategic direction.